Professor Kieran Clarke joined the University of Oxford in 1991. She has a BSc (Hons) from Flinders University and a PhD in Biochemistry from the University of Queensland in Australia. Prior to her current appointment, she was a Group Leader for the National Research Council of Canada after conducting postdoctoral research at Harvard University Medical School.
Professor Clarke has over 25 years’ experience in magnetic resonance (MR) imaging and spectroscopy. She works on the effects of diet on energy metabolism in heart, brain and skeletal muscle, and thereby on physical performance and cognitive function. Specifically, her work has led to the development of a fourth food group, a ketone ester called ΔG®, that improves endurance performance and could be used for the management of common metabolic diseases, such as type 2 diabetes, heart failure and Alzheimer’s disease.